Search Within

Robert Motzer

  1. "Molecular Pharmacology and Chemistry Program Faculty"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (6)
Groups
  1. Department of Medicine (15)
  2. Genitourinary Oncology Service (15)
  3. Molecular Pharmacology and Chemistry Program Faculty (15)
  4. Sloan Kettering Institute Faculty (15)
  5. Solid Tumor Oncology Division (15)
  6. GSK Faculty (14)

More Groups

People
  1. Steven Larson (10)
  2. Chaitanya Divgi (6)
  3. Lloyd Old (6)
  4. Sydney Welt (6)
  5. Darren Feldman (4)
  6. Neeta Pandit-Taskar (4)

More People

Years
  1. 2025 (1)
  2. 2023 (1)
  3. 2022 (1)
  4. 2016 (1)
  5. 2014 (1)
  6. 2013 (1)

More Years

Publications
  1. Journal of Clinical Oncology (4)
  2. Journal of Nuclear Medicine (4)
  3. Radiology (2)
  4. Bone Marrow Transplantation (1)
  5. European Journal of Cancer (1)
  6. European Journal of Nuclear Medicine (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (4)
  2. Society of Nuclear Medicine (4)
  3. Elsevier Inc. (2)
  4. Radiological Society of North America, Inc. (2)
  5. American Association for Cancer Research (1)
  6. Nature Publishing Group (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fractionated radioimmunotherapy with I-131 chimeric antibody G250 (cG250) in metastatic renal cancer
    Meeting Abstract

    Divgi, C. R.; O'Donoghue, J. A.; McGagh, D.; Anwar, K.; Motzer, R.; Welt, S.; Larson, S. M.; Old, L. J.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Radioimmunotherapy with I-131-G250 in metastatic renal cell cancer (RCC)
    Meeting Abstract

    Divgi, C. R.; Bander, N. H.; Welt, S.; Scott, A. M.; Gulec, S.; Motzer, R.; Finn, R. D.; Oosterwijk, E.; Williams, J.; Broussard, E.; more...
    Journal of Nuclear Medicine (1995)

    Fulltext@MSK | Save
  • Phase I radioimmunotherapy trial of I-131 labeled monoclonal antibody G250 in metastatic renal cancer
    Meeting Abstract

    Divgi, C. R.; Bander, N. H.; Scott, A. M.; Welt, S.; Dantis, L.; Motzer, R.; Oosterwijk, E. E.; Larson, S. M.; Old, L. J.
    Proceedings of the American Association for Cancer Research Annual Meeting (1994)

    Fulltext@MSK | Save
  • Radioimmunotherapy (RIT) with I-131 monoclonal antibody (MAB) G250 in metastatic renal cancer
    Meeting Abstract

    Divgi, C. R.; Bander, N. H.; Graham, M. C.; Scott, A. M.; Welt, S.; Motzer, R. J.; Oosterwijk, E.; Larson, S. M.; Old, L. J.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save
  • Autologous bone marrow transplantation for acute myelogenous leukemia using 4-hydroperoxycyclophosphamide and VP-16 purged bone marrow
    Journal Article

    Gulati, S.; Acaba, L.; Yahalom, J.; Reich, L.; Motzer, R.; Crown, J.; Doherty, M.; Clarkson, B.; Berman, E.; Atzpodien, J.; more...
    Bone Marrow Transplantation (1992)

    Fulltext@MSK | Save